Cataclot for injection 40mg, manufactured by Maruishi Pharmaceutical, contains sodium ozagrel. This drug, with YJ code 3999411D2028 and standard 40mg 1 bottle, is a thromboxane A2 synthetase inhibitor indicated for the treatment of cerebral infarction.
Cataclot for injection 40mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →